Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Detection and validation of QTLs for milky-white grains caused by high temperature during the ripening period in Japonica rice.

Miyahara K, Wada T, Sonoda JY, Tsukaguchi T, Miyazaki M, Tsubone M, Yamaguchi O, Ishibashi M, Iwasawa N, Umemoto T, Kondo M.

Breed Sci. 2017 Sep;67(4):333-339. doi: 10.1270/jsbbs.16203. Epub 2017 Jul 28.

2.

Reprogramming towards totipotency is greatly facilitated by synergistic effects of small molecules.

Miyamoto K, Tajima Y, Yoshida K, Oikawa M, Azuma R, Allen GE, Tsujikawa T, Tsukaguchi T, Bradshaw CR, Jullien J, Yamagata K, Matsumoto K, Anzai M, Imai H, Gurdon JB, Yamada M.

Biol Open. 2017 Apr 15;6(4):415-424. doi: 10.1242/bio.023473.

3.

Detection of QTLs for white-back and basal-white grains caused by high temperature during ripening period in japonica rice.

Wada T, Miyahara K, Sonoda JY, Tsukaguchi T, Miyazaki M, Tsubone M, Ando T, Ebana K, Yamamoto T, Iwasawa N, Umemoto T, Kondo M, Yano M.

Breed Sci. 2015 Jun;65(3):216-25. doi: 10.1270/jsbbs.65.216. Epub 2015 Jun 1.

4.

Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3-BAIAP2L1.

Nakanishi Y, Akiyama N, Tsukaguchi T, Fujii T, Satoh Y, Ishii N, Aoki M.

Mol Cancer Ther. 2015 Mar;14(3):704-12. doi: 10.1158/1535-7163.MCT-14-0927-T. Epub 2015 Jan 14.

5.

Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer.

Kodama T, Tsukaguchi T, Satoh Y, Yoshida M, Watanabe Y, Kondoh O, Sakamoto H.

Mol Cancer Ther. 2014 Dec;13(12):2910-8. doi: 10.1158/1535-7163.MCT-14-0274. Epub 2014 Oct 27.

6.

The fibroblast growth factor receptor genetic status as a potential predictor of the sensitivity to CH5183284/Debio 1347, a novel selective FGFR inhibitor.

Nakanishi Y, Akiyama N, Tsukaguchi T, Fujii T, Sakata K, Sase H, Isobe T, Morikami K, Shindoh H, Mio T, Ebiike H, Taka N, Aoki Y, Ishii N.

Mol Cancer Ther. 2014 Nov;13(11):2547-58. doi: 10.1158/1535-7163.MCT-14-0248. Epub 2014 Aug 28.

7.

A novel mechanism of EML4-ALK rearrangement mediated by chromothripsis in a patient-derived cell line.

Kodama T, Motoi N, Ninomiya H, Sakamoto H, Kitada K, Tsukaguchi T, Satoh Y, Nomura K, Nagano H, Ishii N, Terui Y, Hatake K, Ishikawa Y.

J Thorac Oncol. 2014 Nov;9(11):1638-46. doi: 10.1097/JTO.0000000000000311.

8.

Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance.

Kodama T, Tsukaguchi T, Yoshida M, Kondoh O, Sakamoto H.

Cancer Lett. 2014 Sep 1;351(2):215-21. doi: 10.1016/j.canlet.2014.05.020. Epub 2014 Jun 2.

PMID:
24887559
9.

Details of the ultrafast DNA photo-cross-linking reaction of 3-cyanovinylcarbazole nucleoside: cis-trans isomeric effect and the application for SNP-based genotyping.

Fujimoto K, Yamada A, Yoshimura Y, Tsukaguchi T, Sakamoto T.

J Am Chem Soc. 2013 Oct 30;135(43):16161-7. doi: 10.1021/ja406965f. Epub 2013 Oct 22.

PMID:
24087918
10.

Enhanced antitumor activity of erlotinib in combination with the Hsp90 inhibitor CH5164840 against non-small-cell lung cancer.

Ono N, Yamazaki T, Tsukaguchi T, Fujii T, Sakata K, Suda A, Tsukuda T, Mio T, Ishii N, Kondoh O, Aoki Y.

Cancer Sci. 2013 Oct;104(10):1346-52. doi: 10.1111/cas.12237. Epub 2013 Aug 20.

11.

Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802).

Kinoshita K, Asoh K, Furuichi N, Ito T, Kawada H, Hara S, Ohwada J, Miyagi T, Kobayashi T, Takanashi K, Tsukaguchi T, Sakamoto H, Tsukuda T, Oikawa N.

Bioorg Med Chem. 2012 Feb 1;20(3):1271-80. doi: 10.1016/j.bmc.2011.12.021. Epub 2011 Dec 22.

PMID:
22225917
12.

9-substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as highly selective and potent anaplastic lymphoma kinase inhibitors.

Kinoshita K, Kobayashi T, Asoh K, Furuichi N, Ito T, Kawada H, Hara S, Ohwada J, Hattori K, Miyagi T, Hong WS, Park MJ, Takanashi K, Tsukaguchi T, Sakamoto H, Tsukuda T, Oikawa N.

J Med Chem. 2011 Sep 22;54(18):6286-94. doi: 10.1021/jm200652u. Epub 2011 Aug 25.

PMID:
21823617
13.

CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant.

Sakamoto H, Tsukaguchi T, Hiroshima S, Kodama T, Kobayashi T, Fukami TA, Oikawa N, Tsukuda T, Ishii N, Aoki Y.

Cancer Cell. 2011 May 17;19(5):679-90. doi: 10.1016/j.ccr.2011.04.004.

14.

Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors.

Kinoshita K, Ono Y, Emura T, Asoh K, Furuichi N, Ito T, Kawada H, Tanaka S, Morikami K, Tsukaguchi T, Sakamoto H, Tsukuda T, Oikawa N.

Bioorg Med Chem Lett. 2011 Jun 15;21(12):3788-93. doi: 10.1016/j.bmcl.2011.04.020. Epub 2011 Apr 22.

PMID:
21561771
15.

A selective and sensitive detection of SNP between rice cultivars by using DNA photoligation.

Yoshimura Y, Okada H, Ohtake T, Tsukaguchi T, Fujimoto K.

Nucleic Acids Symp Ser (Oxf). 2009;(53):199-200. doi: 10.1093/nass/nrp100.

PMID:
19749329
16.

SNP genotyping by DNA photoligation: application to SNP detection of genes from food crops.

Yoshimura Y, Ohtake T, Okada H, Ami T, Tsukaguchi T, Fujimoto K.

Sci Technol Adv Mater. 2009 Jul 14;10(3):034603. eCollection 2009 Jun.

17.

Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors.

Asoh K, Kohchi M, Hyoudoh I, Ohtsuka T, Masubuchi M, Kawasaki K, Ebiike H, Shiratori Y, Fukami TA, Kondoh O, Tsukaguchi T, Ishii N, Aoki Y, Shimma N, Sakaitani M.

Bioorg Med Chem Lett. 2009 Mar 15;19(6):1753-7. doi: 10.1016/j.bmcl.2009.01.074. Epub 2009 Feb 11.

PMID:
19217288
18.

Synthesis and antifungal activities of novel 1,3-beta-D-glucan synthase inhibitors. Part 2.

Masubuchi K, Okada T, Kohchi M, Murata T, Tsukazaki M, Kondoh O, Yamazaki T, Satoh Y, Ono Y, Tsukaguchi T, Kobayashi K, Ono N, Inoue T, Horii I, Shimma N.

Bioorg Med Chem Lett. 2001 May 21;11(10):1273-6.

PMID:
11392535
19.

The dithiane Ro 44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivo.

Eliason JF, Sawada R, Tsukaguchi T, Kobayashi K, Ichihara S, Konishi C, Horii I, Kuruma I, Ramuz H.

Eur J Cancer. 1995 Dec;31A(13-14):2354-61.

PMID:
8652269
20.

Anti-proliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro.

Eliason JF, Kaufmann F, Tanaka T, Tsukaguchi T.

Br J Cancer. 1993 Jun;67(6):1293-8.

21.

Supplemental Content

Loading ...
Support Center